The c-erbB-2 proto-oncogene as a prognostic and predictive marker in breast cancer: A paradigm for the development of other macromolecular markers-A review (Q40442632)

From Wikidata

Jump to navigation Jump to search

scientific article published on June 14, 1995

Language	Label	Description	Also known as
English	The c-erbB-2 proto-oncogene as a prognostic and predictive marker in breast cancer: A paradigm for the development of other macromolecular markers-A review	scientific article published on June 14, 1995

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

1 reference

Europe PubMed Central

The c-erbB-2 proto-oncogene as a prognostic and predictive marker in breast cancer: a paradigm for the development of other macromolecular markers--a review (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

The c-erbB-2 proto-oncogene as a prognostic and predictive marker in breast cancer: A paradigm for the development of other macromolecular markers-A review (English)

1 reference

10.1016/0378-1119(94)00866-Q

https://api.crossref.org/works/10.1016/0378-1119(94)00866-Q

12 June 2024

1 reference

based on heuristic

inferred from title

author name string

P. M. Ravdin

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7607568

12 June 2024

G. C. Chamness

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7607568

12 June 2024

language of work or name

0 references

publication date

1 June 1995

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

14 June 1995

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7607568

12 June 2024

full work available at URL

https://api.elsevier.com/content/article/PII:037811199400866Q?httpAccept=text/xml

1 reference

10.1016/0378-1119(94)00866-Q

https://api.crossref.org/works/10.1016/0378-1119(94)00866-Q

12 June 2024

https://api.elsevier.com/content/article/PII:037811199400866Q?httpAccept=text/plain

1 reference

10.1016/0378-1119(94)00866-Q

https://api.crossref.org/works/10.1016/0378-1119(94)00866-Q

12 June 2024

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

159

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

19-27

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinoma

2

1 reference

10.1016/0378-1119(94)00866-Q

https://api.crossref.org/works/10.1016/0378-1119(94)00866-Q

12 June 2024

Association of c-erbB-2 expression and S-phase fraction in the prognosis of node positive breast cancer

3

1 reference

10.1016/0378-1119(94)00866-Q

https://api.crossref.org/works/10.1016/0378-1119(94)00866-Q

12 June 2024

An immunohistochemical evaluation of c-erbB-2 expression in human breast carcinoma

4

1 reference

10.1016/0378-1119(94)00866-Q

https://api.crossref.org/works/10.1016/0378-1119(94)00866-Q

12 June 2024

Immunohistochemical assay of neu/c-erbB-2 oncogene product in paraffin-embedded tissues in early breast cancer: retrospective follow-up study of 245 stage I and II cases

5

1 reference

10.1016/0378-1119(94)00866-Q

https://api.crossref.org/works/10.1016/0378-1119(94)00866-Q

12 June 2024

Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu

6

1 reference

10.1016/0378-1119(94)00866-Q

https://api.crossref.org/works/10.1016/0378-1119(94)00866-Q

12 June 2024

c-myc amplification is a better prognostic factor than HER2/neu amplification in primary breast cancer

7

1 reference

10.1016/0378-1119(94)00866-Q

https://api.crossref.org/works/10.1016/0378-1119(94)00866-Q

12 June 2024

Prognostic significance of c-erbB-2 expression in node negative breast cancer

8

1 reference

10.1016/0378-1119(94)00866-Q

https://api.crossref.org/works/10.1016/0378-1119(94)00866-Q

12 June 2024

HER-2/neu amplification predicts poor survival in node-positive breast cancer

9

1 reference

10.1016/0378-1119(94)00866-Q

https://api.crossref.org/works/10.1016/0378-1119(94)00866-Q

12 June 2024

Human breast cancer: prognostic significance of the c-erbB-2 oncoprotein compared with epidermal growth factor receptor, DNA ploidy, and conventional pathologic features

11

1 reference

10.1016/0378-1119(94)00866-Q

https://api.crossref.org/works/10.1016/0378-1119(94)00866-Q

12 June 2024

c-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes

12

1 reference

10.1016/0378-1119(94)00866-Q

https://api.crossref.org/works/10.1016/0378-1119(94)00866-Q

12 June 2024

Why do so many prognostic factors fail to pan out?

14

1 reference

10.1016/0378-1119(94)00866-Q

https://api.crossref.org/works/10.1016/0378-1119(94)00866-Q

12 June 2024

Immunohistochemical study on the expression of c-erbB-2 oncoprotein in breast cancer

15

1 reference

10.1016/0378-1119(94)00866-Q

https://api.crossref.org/works/10.1016/0378-1119(94)00866-Q

12 June 2024

Association of c-erbB-2 protein over-expression with high rate of cell proliferation, increased risk of visceral metastasis and poor long-term survival in breast cancer

17

1 reference

10.1016/0378-1119(94)00866-Q

https://api.crossref.org/works/10.1016/0378-1119(94)00866-Q

12 June 2024

Cell biological factors associated with the response of breast cancer to systemic treatment

18

1 reference

10.1016/0378-1119(94)00866-Q

https://api.crossref.org/works/10.1016/0378-1119(94)00866-Q

12 June 2024

When is a prognostic factor useful? A guide for the perplexed

19

1 reference

10.1016/0378-1119(94)00866-Q

https://api.crossref.org/works/10.1016/0378-1119(94)00866-Q

12 June 2024

c-erbB-2 oncoprotein expression in primary and advanced breast cancer

20

1 reference

10.1016/0378-1119(94)00866-Q

https://api.crossref.org/works/10.1016/0378-1119(94)00866-Q

12 June 2024

Prognostic significance of c-erbB-2 and estrogen receptor status in human breast cancer

21

1 reference

10.1016/0378-1119(94)00866-Q

https://api.crossref.org/works/10.1016/0378-1119(94)00866-Q

12 June 2024

Breast cancer prognostic factors: evaluation guidelines.

22

1 reference

10.1016/0378-1119(94)00866-Q

https://api.crossref.org/works/10.1016/0378-1119(94)00866-Q

12 June 2024

c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer

24

1 reference

10.1016/0378-1119(94)00866-Q

https://api.crossref.org/works/10.1016/0378-1119(94)00866-Q

12 June 2024

C-erbB-2 oncoprotein expression versus internal mammary lymph node metastases as additional prognostic factors in patients with axillary lymph node-positive breast cancer

25

1 reference

10.1016/0378-1119(94)00866-Q

https://api.crossref.org/works/10.1016/0378-1119(94)00866-Q

12 June 2024

The relationship between c-erbB-2 expression, S-phase fraction and prognosis in breast cancer

26

1 reference

10.1016/0378-1119(94)00866-Q

https://api.crossref.org/works/10.1016/0378-1119(94)00866-Q

12 June 2024

Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: prognostic significance of erbB-2 protein overexpression in primary breast cancer

27

1 reference

10.1016/0378-1119(94)00866-Q

https://api.crossref.org/works/10.1016/0378-1119(94)00866-Q

12 June 2024

Prognostic significance of her-2/neu expression in breast cancer and its relationship to other prognostic factors

31

1 reference

10.1016/0378-1119(94)00866-Q

https://api.crossref.org/works/10.1016/0378-1119(94)00866-Q

12 June 2024

c-erbB-2 positive breast tumours behave more aggressively in the first years after diagnosis

32

1 reference

10.1016/0378-1119(94)00866-Q

https://api.crossref.org/works/10.1016/0378-1119(94)00866-Q

12 June 2024

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

33

1 reference

10.1016/0378-1119(94)00866-Q

https://api.crossref.org/works/10.1016/0378-1119(94)00866-Q

12 June 2024

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

34

1 reference

10.1016/0378-1119(94)00866-Q

https://api.crossref.org/works/10.1016/0378-1119(94)00866-Q

12 June 2024

HER-2/neu oncogene protein and prognosis in breast cancer

35

1 reference

10.1016/0378-1119(94)00866-Q

https://api.crossref.org/works/10.1016/0378-1119(94)00866-Q

12 June 2024

C-erbB-2-oncogene expression in breast carcinoma: analysis by S1 nuclease protection assay and immunohistochemistry in relation to clinical parameters

36

1 reference

10.1016/0378-1119(94)00866-Q

https://api.crossref.org/works/10.1016/0378-1119(94)00866-Q

12 June 2024

Analysis of c-erbB-2 expression in breast carcinomas with clinical follow-up

38

1 reference

10.1016/0378-1119(94)00866-Q

https://api.crossref.org/works/10.1016/0378-1119(94)00866-Q

12 June 2024

Reduced expression of nm23-H1, but not of nm23-H2, is concordant with the frequency of lymph-node metastasis of human breast cancer

39

1 reference

10.1016/0378-1119(94)00866-Q

https://api.crossref.org/works/10.1016/0378-1119(94)00866-Q

12 June 2024

Immunohistochemical study on overexpression of c-erbB-2 protein in human breast cancer: its correlation with gene amplification and long-term survival of patients

40

1 reference

10.1016/0378-1119(94)00866-Q

https://api.crossref.org/works/10.1016/0378-1119(94)00866-Q

12 June 2024

The long term prognostic significance of c-erbB-2 in primary breast cancer

42

1 reference

10.1016/0378-1119(94)00866-Q

https://api.crossref.org/works/10.1016/0378-1119(94)00866-Q

12 June 2024

Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancer

43

1 reference

10.1016/0378-1119(94)00866-Q

https://api.crossref.org/works/10.1016/0378-1119(94)00866-Q

12 June 2024

Response to mitoxantrone in advanced breast cancer: correlation with expression of c-erbB-2 protein and glutathione S-transferases

44

1 reference

10.1016/0378-1119(94)00866-Q

https://api.crossref.org/works/10.1016/0378-1119(94)00866-Q

12 June 2024

Predicting outcome for patients with node negative breast cancer: a comparative study of the value of flow cytometry and cell image analysis for determination of DNA ploidy

45

1 reference

10.1016/0378-1119(94)00866-Q

https://api.crossref.org/works/10.1016/0378-1119(94)00866-Q

12 June 2024

Identifiers

10.1016/0378-1119(94)00866-Q

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40442632&oldid=2176854690"